In 2023, healthcare expenditure on prescribed medicines in Denmark was valued at 1.38 billion Euros. From the actual data of 2023 to the forecasted data of 2024, we observe a year-on-year increase of approximately 0.72%. This upward trend continues slightly into 2025, reaching 1.4 billion Euros, maintaining a small increase from the previous year. From 2025 to 2028, the expenditure stabilizes at 1.4 billion Euros, reflecting no additional growth year-on-year during this period. Looking back at the last two years, the compound annual growth rate (CAGR) from 2023 to 2028 is approximately 0.29% annually.
Future trends to watch for include the potential impact of new healthcare policies, technological advancements in pharmaceutical development, and demographic changes. Monitoring these factors could provide insights into whether this stabilization will persist or if there will be shifts in expenditure patterns in the upcoming years.
